NASDAQ | TSX: ACB
Sports-oriented KG7 now available at
relivacbd.com and in convenience stores across the U.S.
EDMONTON, AB, Feb. 3, 2022 /PRNewswire/ - Reliva, a leading
American CBD brand and subsidiary of Aurora Cannabis Inc. (NASDAQ:
ACB) (TSX: ACB), the Canadian company defining the future of
cannabinoids worldwide, announced today the launch of KG7, a new
high-quality CBD product line developed for adult consumers with an
active lifestyle. KG7 and Reliva products are available for
purchase at https://relivacbd.com/ and in convenience stores across
the United States.
"We're excited to introduce KG7 to the Reliva family of leading
CBD products," says Miguel Martin,
Chief Executive Officer of Aurora Cannabis. "As part of Reliva's
portfolio expansion strategy, KG7 extends our brand into additional
CBD market segments. With this product line, we expect to solidify
Reliva's position as the #1 CBD brand in brick and mortar
channels."
KG7's lineup of CBD products includes delicious, pectin-based
gummies made with natural flavors and colors; topical creams
formulated with ingredients such as arnica and shea butter; and
gluten-free CBD oil and drink mixes.
Standing by its zero THC policy, each batch of KG7 is made with
100% hemp-derived CBD isolate and is 100% free of THC. All KG7
products are independent lab-verified and traceable to provide the
safest and heathiest hemp products for physically active
individuals.
The KG7 product lineup includes:
KG7 CBD Gummies:
20mg & 50mg Gummies
KG7 CBD Topicals:
250mg Stick
300mg Cream
30mg Travel-size Cream Packet
KG7 CBD Oils:
500mg Mint CBD Oil
KG7 CBD Drink Mixes:
25mg Burst (grape flavor)
25mg Smash (citrus flavor)
Reliva is the #1 CBD brand in brick and mortar channel, as
ranked by Nielsen.
About Reliva:
Reliva is a leader in delivering high quality, hemp-derived CBD
products to consumers. Built on a philosophy of compliance,
testing, product innovation and approachable price points, Reliva
has grown to become one of the largest retail CBD brands in the
U.S. Supported through long-term partnerships with leading national
wholesalers and retailers, Reliva's products can be found in over
20,000 retail stores. For more information, visit
https://relivacbd.com/.
About Aurora:
Aurora is a global leader in the cannabis industry, serving
both the medical and consumer markets. Headquartered in
Edmonton, Alberta, Aurora is a
pioneer in global cannabis dedicated to helping people improve
their lives. The Company's brand portfolio includes
Aurora, Aurora Drift, San Rafael '71, Daily
Special, MedReleaf, CanniMed, Whistler, Reliva and KG7
CBD. Driven by science and innovation, and with a focus on
high-quality cannabis products, Aurora's brands continue to break
through as industry leaders in the medical, performance,
wellness and adult recreational markets
wherever they are launched. Learn more
at www.auroramj.com and follow us
on Twitter and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB" and is a constituent of the S&P/TSX Composite
Index.
Forward-looking Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements
regarding the launch of new products. These forward-looking
statements are only predictions. Various assumptions were used in
drawing the conclusions or making the projections contained in the
forward-looking statements throughout this news release. Forward
looking statements are based on the opinions, estimates and
assumptions of management in light of management's experience and
perception of historical trends, current conditions and expected
developments at the date the statements are made, such as current
and future market conditions, the ability to maintain SG&A
costs in line with current expectations, the ability to achieve
high margin revenues in the Canadian consumer market, the current
and future regulatory environment and future approvals and permits.
Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be
relevant and reasonable in the circumstances could cause actual
events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements, including the risks
associated with: entering the U.S. market, the ability to realize
the anticipated benefits associated with the acquisition of Reliva,
achievement of Aurora's business transformation plan, general
business and economic conditions, changes in laws and regulations,
product demand, changes in prices of required commodities,
competition, the effects of and responses to the COVID-19 pandemic
and other risks, uncertainties and factors set out under the
heading "Risk Factors" in the Company's annual information form
dated September 27, 2021 (the "AIF")
and filed with Canadian securities regulators available on the
Company's issuer profile on SEDAR at www.sedar.com and filed
with and available on the SEC's website at www.sec.gov. The Company
cautions that the list of risks, uncertainties and other factors
described in the AIF is not exhaustive and other factors could also
adversely affect its results. Readers are urged to consider the
risks, uncertainties and assumptions carefully in evaluating the
forward-looking statements and are cautioned not to place undue
reliance on such information. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabiss-reliva-expands-portfolio-with-new-cbd-brand-kg7-301474714.html
SOURCE Aurora Cannabis Inc.